ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2025; 15(4): 135-141


Harnessing the potential of TiO2 nanoparticles from marine macroalgae Ulva lactuca for antibacterial, anti-inflammatory, and cytotoxic properties

Mohamed Sitheeq Afra Mariyam, Subburayan RR, Ganapathy Dhanraj.




Abstract

The present investigation explores the green synthesis of titanium dioxide nanoparticles (NPs) using an aqueous extract of Ulva lactuca, a medicinally important marine macroalgae. Characterization of UL-TiO2NPs showed an intense peak at 371 nm. Fourier transform-infrared spectroscopy analysis showed the presence of functional groups such as hydroxyls, carbonyls, methylene, aliphatic and aromatic hydrocarbons, amines, and ethers. X-ray diffraction confirmed the crystalline nature of the biosynthesized UL-TiO2NPs with sizes in the range of 20 and 50 nm. Scanning electron microscope analysis emphasized the morphology of TiO2NPs to be spherical-shaped with minimal clustering. Antibacterial activity indicated profound inhibitory zones against clinical isolates (12–19 mm) rather than against microbial type culture collection bacterial pathogens (9–14 mm). The anti-inflammatory activity of the UL-TiO2NPs was affirmed by a remarkable reduction (22%–78%) of protein denaturation. Anticancer activity of UL-TiO2NPs against oral oral carcinoma cell line carcinoma cells showed a notable reduction in viability of cells (94.31%–17.4%) with respect to an increase in concentrations and recorded an IC50 value of 28.74 μg/ml. Thus, the distinct properties of biologically synthesized titanium dioxide NPs imply that they could be efficiently utilized as a nano-antibiotic coating on the surface of healthcare devices and as a drug carrier in anticancer studies.

Key words: Ulva lactuca, TiO2NPs, Antibacterial, Anti-inflammatory, Cytotoxicity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.